A case report of a novel, integrative approach to Hashimoto's thyroiditis with unexpected results. Issue 2 (August 2018)

• Record Type: Journal Article
• Authors: Avard, Nicole; Grant, Suzanne J.
• Is Part Of: Advances in integrative medicine. Volume 5:Issue 2(2018)
• Page Start: 75
• Page End: 79
• Publication Date: 2018-08
• Subjects: Hashimotos -- Dietary intervention -- Methylation -- Selenium -- Micronutrients -- Autoimmune thyroiditis; Integrative medicine -- Periodicals; Alternative medicine -- Periodicals; Integrative Medicine -- Periodicals; Alternative medicine; Integrative medicine; Periodicals; 615.505
• DOI: 10.1016/j.aimed.2018.03.003
• Languages: English
• ISSNs: 2212-9588

Abstract

Abstract: Background: Hashimoto's thyroiditis (HT) is an autoimmune illness of the thyroid gland. The presence of thyroid antibodies (Thyroglobulin Antibodies and Peroxidase Antibodies) is suggestive of the diagnosis. Patients can have Hashimoto's thyroiditis without the presence of thyroid antibodies. The treatment of Hashimoto's thyroiditis is usually expectant observation of the thyroid function and subsequent exogenous thyroid hormone replacement, if deemed appropriate. This case report outlines a novel approach that led to an improvement in symptoms, and a reduction in one thyroid antibody, for a young woman. Case: A 23 year old woman diagnosed with Hashimoto's thyroiditis, 8 months prior, presented at her initial visit with symptoms of extreme fatigue, anxiety and hair loss. Her thyroid antibodies were strongly positive, with a normal TSH. She was commenced on a three-tiered integrative treatment plan, implemented by the clinic naturopath and general practitioner, working in a collaborative care model. This involved a gluten and grain free diet, support of her methylation cycle and anti-oxidant capacity with micronutrients, and stress management. Conclusion: Over a treatment period of 15 months, using an integrative approach, she experienced clinical improvement in her symptoms and return to functional daily life, as well as a significant reduction in thyroid antibodies.